ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

DCT Faces Hard Choices, Clinical Group Need Re-Examination, Chabner tells BSC

November 12, 1982

ASCO Releases Guideline On Use Of Growth Factors

May 26, 2006

More Than 3,000 Letters If Intent Sent To army For Breast Programs

September 10, 1993

Also Senate, House committees request further research, reports from NCI.

September 19, 2003

NCI To Merge Two Intramural Divisions To Form Center For Cancer Research.

January 12, 2001

Clinical Trials Approved By NCI

November 26, 2010